An online literature search of PubMed, Cochrane database, and ClinicalTrials.gov was conducted till May 31, 2024, to identify RCTs involving anti-PD1/PD-L1 therapies in oral cancer. The gene discussed is CD274; the disease is lip and oral cavity carcinoma.